Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users

Chamot E, Hirschel B, Wintsch J, Robert CF, Gabriel V, Deglon JJ, et al. Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users. AIDS. 1990;4(12):1275-1277.

Publication Type:

Journal Article

Authors:

Chamot, E.; Hirschel, B.; Wintsch, J.; Robert, C.F.; Gabriel, V.; Deglon, J.J.; Yerly, S.; Perrin, L.

Source:

AIDS, Volume 4, Issue 12, p.1275-1277 (1990)

Keywords:

Adult, analysis, blood, complications, Female, Follow-Up Studies, hepatitis, Hepatitis Antibodies, Hepatitis C, Hepatitis C-Like Viruses, Hiv, HIV Seropositivity, Human, immunology, Male, Methadone, Substance Abuse,Intravenous, Support,Non-U.S.Gov't, United States

Cited On:

Management of Acute HCV Infection

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/0001965126

Export Citation:

RIS Format

Top